The Royal Wolverhampton NHS Trust
Wolverhampton, West Midlands, WV10 0QP, United Kingdom
Location status: Recruiting
NCT Number: NCT04741230
Cornea ectatic conditions such as keratoconus and post-LASIK (Laser In situ Keratomileusis) ectasia are disorders of the eye that are notorious for its uncontrolled progression over time, leading to loss of vision. There are valuable treatment options for controlling disease progression in mild to moderate stages of such disease. However in advanced cases and / or when contact lenses cannot be worn, surgery remains the only treatment option to rehabilitate vision. Most treatment options are highly invasive and represent significant risks. This study evaluates a novel corneal implant, Gebauer™ Lenticule to treat severe keratoconus or post-LASIK ectasia. This implant is derived from porcine collagen and intended for intra-stromal insertion. The Gebauer™ Lenticule is expected to improve the stability of the cornea while not impairing the vision. The procedure is an additive procedure after other treatment options have been exhausted. The procedure is reversible with removal of the implant (in the unexpected case of an adverse reaction), and vision may be restored to baseline.
The purpose of this study is to evaluate how well the implant is tolerated, it's safety profile, and how effective this new treatment option is in the treatment of keratoconus or post-LASIK ectasia.
Interested in participating?
Request Info18 year–79 year
All sexes
Interventional
Not applicable
Wolverhampton, West Midlands, WV10 0QP, United Kingdom
Location status: Recruiting
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The Gebauer™ Lenticule corneal implant device is a custom-made device intended for patients suffering from keratoconus or post-LASIK ectasia. The device is expected to reinforce and stabilize the patient's cornea, so that a more consistent refraction is induced and a penetrating human cornea donor transplantation may be avoided or postponed.
Time frame: 6 months
Signs of immunological rejection during the post implantation observation period
Time frame: 6 months
The frequency and severity of all treatment-related adverse events, during implantation of the Gebauer™ Lenticule and throughout the post implantation observation period.
Time frame: 6 months
Changes in corneal topography (central K-reading results): at baseline vs. post implantation observation period
Time frame: 6 months
Changes in central corneal thickness at baseline vs. post implantation corneal thickness (cornea plus lenticule)
Contact information is provided by the study sponsor or research team.
The Royal Wolverhampton Hospitals NHS Trust
Other Gov
Prospective, Investigator Initiated Feasibility Study to Evaluate the Safety, and Indicative Effectiveness of Gebauer™ Lenticules in Patients Suffering From Severe Keratoconus or Post LASIK Ectasia
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07629557
Corneal Diseases, Eye Diseases
Westerville, Ohio, United States
View Trial DetailsNCT03030755
Cornea; Ectasia, Corneal Diseases
Cleveland, Ohio, United States
View Trial DetailsNCT03923101
Corneal Diseases, Eye Diseases
Homburg, Saarland, Germany
View Trial DetailsNCT02138669
Corneal Diseases, Eye Diseases
Dallas, Texas, United States
View Trial Details